Difference between revisions of "Part:BBa K2206011:Design"
(→Design Notes) |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 9: | Line 9: | ||
The hybridisation domain for hsa-miR-27b-3p must be perfectly complementary to the 3' end of hsa-miR-27b-3p. | The hybridisation domain for hsa-miR-27b-3p must be perfectly complementary to the 3' end of hsa-miR-27b-3p. | ||
| − | + | Outside of the microRNA hybridisation domain, the anti-miRNA has no sequence constraints. | |
===Source=== | ===Source=== | ||
| − | This part is a synthetic toehold switch that was designed in | + | This part is a synthetic toehold switch that was designed in silico. |
===References=== | ===References=== | ||
Latest revision as of 23:47, 19 October 2017
Anti-miRNA for hsa-miR-27b-3p
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
The hybridisation domain for hsa-miR-27b-3p must be perfectly complementary to the 3' end of hsa-miR-27b-3p.
Outside of the microRNA hybridisation domain, the anti-miRNA has no sequence constraints.
Source
This part is a synthetic toehold switch that was designed in silico.